Federal Register notice: FDA announces the completion of the first phase of its enhanced Purple Book for biologics.
FDA announces a 4/7 public meeting on reauthorizing the Medical Device User Fee Amendments for fiscal years 2023 through 2027.
FDA commissioner Stephen Hahn updates agency education, data-gathering, and enforcement actions for CBD products.
Vice president Mike Pence admits that the government will not meet its projected goal of delivering one million coronavirus tests throughout the U.S. ...
FDA publishes a draft guidance on including older adults in oncology clinical trials.
FDA publishes a final rule banning electrical stimulation devices for self-injurious or aggressive behavior.
FDA publishes a question-and-answer guidance on the transition provision of the Biologics Price Competition and Innovation Act under which application...
Federal Register notice: FDA seeks comments on an information collection extension for medicated feed GMPs.